MIM software announced that its radiology app Mobile MIM 3.0 has been approved by the US Food and Drug Administration to be used in viewing images to plan for a radiation-based treatment.
The company said that the app provides a number of features for physicians who can use it to display volume histograms, isodose curves and contours along with the ability to consult with other physicians.
AdvertisementAnnouncing FDA's decision, MIM software's director Jerimy Brockway said, "Making Mobile MIM intuitive for radiation oncology was a primary goal, and we focused on creating the most natural and streamlined experience possible. The feedback so far has been overwhelmingly positive."
P Recovery in Stroke Patients may be Hastened by Magnetic Stimulation of Brain DHEA can Relieve Menopausal Symptoms and Revive Sex Lives in Older Women M
You May Also Like